Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Amlenetug for Patients with Multiple System Atrophy
PolandStudy of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy
PolandStudy on the Safety and Effects of ORG-129 in Patients with Fibrostenotic Crohn's Disease
PolandStudy on Empagliflozin and Dapagliflozin for Patients Hospitalized with Acute Heart Failure
PolandStudy on Atorvastatin for Reducing COPD Exacerbations in Smokers with Chronic Obstructive Pulmonary Disease
PolandStudy of TL-895 and Navtemadlin for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PolandStudy of TX000045 for Pulmonary Hypertension in Heart Failure Patients with Preserved Ejection Fraction
PolandStudy on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome
PolandStudy Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer
PolandStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
PolandStudy on the Safety of Ticagrelor and Aspirin in Patients with Acute Coronary Syndrome
PolandStudy of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
